COVID-19 Made Its Mark On the R&D Pipeline And Novel Drug Launches In 2020
Executive Summary
A new analysis reveals the impact of the coronavirus pandemic on pharma R&D in 2020 in two quarters: the total size of the pipeline and in the number of novel products launched in their first markets.